Skip to main content
. 2011 Jan;101(1):101–111. doi: 10.2105/AJPH.2009.175331

TABLE 2.

Comparison of Demographic, Clinical, and Risk Factor Characteristics of Tuberculosis (TB) Patients, by Birth Country and Ethnicity: United States, 2000–2007

Foreign-Born Filipinos (n = 7 038), No. (%) US-Born Non-Hispanic Whites (n = 18 907), No. (%) OR (95% CI)
Age at diagnosis, y
    > 44 4306 (61.2) 14 042 (74.3) 0.55 (0.51, 0.58)
    ≤ 44 (Ref) 2731 (38.8) 4 862 (25.7) 1.00
Gender
    Female 3250 (46.2) 6 174 (32.7) 1.77 (1.67, 1.87)
    Male (Ref) 3787 (53.8) 12 729 (67.3) 1.00
Mortality at diagnosis
    Deceased 68 (1.0) 763 (4.0) 0.23 (0.18, 0.30)
    Living (Ref) 6969 (99.0) 18 136 (95.9) 1.00
Type of TB disease
    Extrapulmonary 1380 (19.6) 2 655 (14.0) 1.50 (1.39, 1.61)
    Extrapulmonary and pulmonary 415 (5.9) 1 140 (6.0) 1.05 (0.93, 1.18)
    Pulmonary (Ref) 5241 (74.5) 15 101 (79.9) 1.00
Chest radiograph result
    Abnormal 5946 (84.5) 16 919 (89.5) 0.54 (0.49, 0.58)
    Normal (Ref) 964 (13.7) 1 468 (7.8) 1.00
Cavitation on chest radiographa
    Cavitary 1214 (20.8) 4 811 (29.0) 0.63 (0.59, 0.68)
    Noncavitary, consistent with TB (Ref) 4312 (73.7) 10 138 (61.2) 1.00b
    Noncavitary, not consistent with TB (Ref) 254 (4.3) 1 302 (7.9) 1.00b
Drug resistancec
    INH monoresistance 718 (13.0) 511 (3.5) 4.13 (3.67, 4.66)
    RIF monoresistance 10 (0.2) 52 (0.4) 0.57 (0.27, 1.15)
    INH and RIF resistance (multidrug resistance) 92 (1.7) 59 (0.4) 4.59 (3.26, 6.46)
    Susceptible to INH and RIF (Ref) 4700 (85.1) 13 826 (95.7) 1.00
Sputum smear test
    Positive 2009 (28.6) 7 188 (38.0) 0.53 (0.50, 0.57)
    Not done 1196 (17.0) 4 354 (23.0) 0.65 (0.60, 0.70)
    Negative (Ref) 3809 (54.1) 7 282 (38.5) 1.00
Therapyd
    Any DOT 4848 (70.2) 13 876 (77.1) 0.70 (0.65, 0.75)
    Self-therapy style (Ref) 1493 (21.6) 2 976 (16.6) 1.00
Outcomed
    Died 306 (4.4) 2 081 (11.6) 0.36 (0.32, 0.41)
    Lost 73 (1.1) 214 (1.2) 0.85 (0.64, 1.11)
    Moved 270 (3.9) 161 (0.9) 4.16 (3.40, 5.09)
    Completed (Ref) 5563 (80.5) 13 796 (76.7) 1.00
Provider typee
    Private 1848 (26.5) 3 971 (21.9) 1.33 (1.25, 1.42)
    Public (Ref) 4544 (65.3) 12 993 (71.6) 1.00
HIV statusf
    Positive 27 (0.8) 796 (4.8) 0.17 (0.11, 0.25)
    Refused 295 (9.0) 1 783 (10.7) 0.81 (0.70, 0.92)
    Not offered 751 (23.0) 3 665 (22.0) 1.00 (0.91, 1.10)
    Negative (Ref) 1906 (58.4) 9 288 (55.7) 1.00
Homeless in past 12 mo
    Yes 48 (0.7) 1 864 (9.9) 0.06 (0.05, 0.08)
    No (Ref) 6938 (98.6) 16 882 (89.3) 1.00
Resident of correctional facility
    Yes 18 (0.3) 606 (3.2) 0.08 (0.05, 0.13)
    No (Ref) 7010 (99.6) 18 280 (96.7) 1.00
Resident of long-term health care facility
    Yes 82 (1.2) 1 116 (5.9) 0.19 (0.15, 0.24)
    No (Ref) 6944 (98.7) 17 763 (93.9) 1.00
Occupation in past 24 mog
    Health care worker 647 (9.2) 460 (2.4) 2.98 (2.62, 3.39)
    Migrant worker 14 (0.2) 14 (0.1) 2.12 (0.95, 4.71)
    Unemployed 1748 (24.8) 5 055 (26.7) 0.84 (0.81, 0.88)
    Other employment (Ref) 2589 (36.8) 5 485 (29.0) 1.00
Excessive alcohol use
    Yes 273 (3.9) 3 907 (20.7) 0.15 (0.14, 0.18)
    No (Ref) 6531 (92.8) 14 450 (76.4) 1.00
Injection drug use
    Yes 8 (0.1) 573 (3.0) 0.04 (0.02, 0.08)
    No (Ref) 6777 (96.3) 17 753 (93.9) 1.00
Noninjection drug use
    Yes 56 (0.8) 1 587 (8.4) 0.09 (0.07, 0.12)
    No (Ref) 6708 (95.3) 16 686 (88.3) 1.00
Previous TB diagnosis
    Yes 473 (6.7) 1 010 (5.3) 1.28 (1.14, 1.43)
    No (Ref) 6499 (92.3) 1 7751 (93.9) 1.00

Note. CI = confidence interval; DOT = directly observed therapy; INH = isoniazid; OR = odds ratio; RIF = rifampin. Unknown and missing data categories were included in analyses if they composed more than 3% of the total (results not shown).

a

Analysis limited to TB patients with abnormal X-ray results: Filipinos (n = 5 780); US-born non-Hispanic Whites (n = 16 251); patients with these data unknown or missing were not included.

b

We pooled noncavitary, consistent with TB and noncavitary, not consistent with TB to compose the referent group.

c

Analysis limited to culture-positive TB patients with isolates that had susceptibility testing performed: Filipinos (n = 5 520); US-born non-Hispanic Whites (n = 14 448); patients with these data unknown or missing data not included.

d

Analysis limited to patients registered in the National Tuberculosis Surveillance System from 2000 to 2005 who were alive at diagnosis and started drug therapy: Filipinos (n = 6 341); US-born non-Hispanic Whites (n = 16 852); patients with these data unknown or missing data not included.

e

Analysis limited to patients who were alive at diagnosis: Filipinos (n = 6 392); US-born non-Hispanic Whites (n = 16 964); patients with these data unknown or missing data not included.

f

Analysis limited to patients registered in the National Tuberculosis Surveillance System from all states excluding California and Vermont: Filipinos (n = 2 979); US-born non-Hispanic Whites (n = 15 532); patients with these data unknown or missing data not included.

g

Patients aged younger than 16 years or older than 65 years included in analysis as a separate group, not eligible for employment (results not shown).